~~<i id='9F79D27BBC'><strike id='9F79D27BBC'><tt id='9F79D27BBC'><pre id='9F79D27BBC'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

explore

author：focus 2025-09-27 16:48:37 - browse：19328

A device component from Paradromics Inc., one of the main brain-computer interface players racing to get to market. Courtesy Paradromics Inc.

Rodney Gorham loves fast, flashy cars: His WhatsApp profile picture is a bright yellow Corvette Stingray. “I don’t get to drive it anymore,” Gorham told STAT in a text.

Gorham, a 63-year-old living in Australia, has amyotrophic lateral sclerosis. He can’t speak, and can move his hands and legs only a little. But he is able to control his computer with his thoughts, aided by a brain-computer interface developed by the startup Synchron.

“It has been exciting to be involved,” Gorham wrote.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen
Next article： BIO selects John Crowley as new CEO

entertainment

explore

leisure time

entertainment

Wikipedia

hotspot

2:13TheZaporizhzhiaNuclearPowerPlantisshownoutsideEnerhodarintheZaporizhzhiaregion,Russian-controlle

WSS

U.K. Biobank has 500,000 peoples' genome sequences available

30 years of 'Listening to Prozac'

Palestinian attacker wounds 8 in Tel Aviv as Israel presses on with West Bank operation

Will the market for weight loss drugs really reach $100 billion?

Churchill Downs extends trainer Bob Baffert's ban through 2024

Readout Newsletter: The latest in Pfizer, Moderna, and Sanofi

focus

explore

entertainment

Continuity nursing helped my family in our darkest PICU moments

BIO selects John Crowley as new CEO

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Will the market for weight loss drugs really reach $100 billion?

The high cost of giving birth even with insurance

Churchill Downs extends trainer Bob Baffert's ban through 2024

Peter Hotez and the public health issue of online harassment

What don’t we know about an Alzheimer’s drug side effect?

DIEP, the 'gold standard' of breast reconstruction, is under threat

ReNAgade cuts staff seven months after raising $300 million

explore

Saudi VC loops Novo Nordisk, biotech VCs into longevity incubator

Elon Musk announces 'temporary limits' for reading Twitter posts

Despite FDA concern, risk that CAR

Will the market for weight loss drugs really reach $100 billion?

Disappointing trial forces Pfizer to pivot on obesity medicine plans

Brazil's Neymar fined $3.3 million for illegal artificial lake at mansion outside Rio

leisure time

entertainment

Wikipedia

hotspot